Literature DB >> 30485186

In vivo histotripsy brain treatment.

Jonathan R Sukovich1, Charles A Cain1, Aditya S Pandey2, Neeraj Chaudhary3, Sandra Camelo-Piragua4, Steven P Allen1, Timothy L Hall1, John Snell5,6, Zhiyuan Xu6, Jonathan M Cannata7, Dejan Teofilovic7, James A Bertolina7, Neal Kassell5, Zhen Xu1.   

Abstract

OBJECTIVE: Histotripsy is an ultrasound-based treatment modality relying on the generation of targeted cavitation bubble clouds, which mechanically fractionate tissue. The purpose of the current study was to investigate the in vivo feasibility, including dosage requirements and safety, of generating well-confined destructive lesions within the porcine brain utilizing histotripsy technology.
METHODS: Following a craniectomy to open an acoustic window to the brain, histotripsy pulses were delivered to generate lesions in the porcine cortex. Large lesions with a major dimension of up to 1 cm were generated to demonstrate the efficacy of histotripsy lesioning in the brain. Gyrus-confined lesions were generated at different applied dosages and under ultrasound imaging guidance to ensure that they were accurately targeted and contained within individual gyri. Clinical evaluation as well as MRI and histological outcomes were assessed in the acute (≤ 6 hours) and subacute (≤ 72 hours) phases of recovery.
RESULTS: Histotripsy was able to generate lesions with a major dimension of up to 1 cm in the cortex. Histotripsy lesions were seen to be well demarcated with sharp boundaries between treated and untreated tissues, with histological evidence of injuries extending ≤ 200 µm from their boundaries in all cases. In animals with lesions confined to the gyrus, no major hemorrhage or other complications resulting from treatment were observed. At 72 hours, MRI revealed minimal to no edema and no radiographic evidence of inflammatory changes in the perilesional area. Histological evaluation revealed the histotripsy lesions to be similar to subacute infarcts.
CONCLUSIONS: Histotripsy can be used to generate sharply defined lesions of arbitrary shapes and sizes in the swine cortex. Lesions confined to within the gyri did not lead to significant hemorrhage or edema responses at the treatment site in the acute or subacute time intervals.

Entities:  

Keywords:  H & E = hematoxylin and eosin; HIFU = high-intensity focused ultrasound; ICH = intracerebral hemorrhage; focused ultrasound; histotripsy; intracerebral hemorrhage; neurosurgery; thrombolysis

Year:  2018        PMID: 30485186      PMCID: PMC6925659          DOI: 10.3171/2018.4.JNS172652

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  41 in total

1.  FOCAL LESIONS IN THE BRAIN OF GROWING RABBITS PRODUCED BY FOCUSED ULTRASOUND.

Authors:  G F YOUNG; P P LELE
Journal:  Exp Neurol       Date:  1964-06       Impact factor: 5.330

2.  The use of radio-frequency power in making lesions in the brain.

Authors:  S ARONOW
Journal:  J Neurosurg       Date:  1960-05       Impact factor: 5.115

3.  Controlled ultrasound tissue erosion: the role of dynamic interaction between insonation and microbubble activity.

Authors:  Zhen Xu; J Brian Fowlkes; Edward D Rothman; Albert M Levin; Charles A Cain
Journal:  J Acoust Soc Am       Date:  2005-01       Impact factor: 1.840

4.  Effect of Frequency and Focal Spacing on Transcranial Histotripsy Clot Liquefaction, Using Electronic Focal Steering.

Authors:  Tyler Gerhardson; Jonathan R Sukovich; Aditya S Pandey; Timothy L Hall; Charles A Cain; Zhen Xu
Journal:  Ultrasound Med Biol       Date:  2017-07-14       Impact factor: 2.998

5.  Demonstration of potential noninvasive ultrasound brain therapy through an intact skull.

Authors:  K Hynynen; F A Jolesz
Journal:  Ultrasound Med Biol       Date:  1998-02       Impact factor: 2.998

6.  Effects of tissue mechanical properties on susceptibility to histotripsy-induced tissue damage.

Authors:  Eli Vlaisavljevich; Yohan Kim; Gabe Owens; William Roberts; Charles Cain; Zhen Xu
Journal:  Phys Med Biol       Date:  2013-12-19       Impact factor: 3.609

7.  Acoustical properties of the human skull.

Authors:  F J Fry; J E Barger
Journal:  J Acoust Soc Am       Date:  1978-05       Impact factor: 1.840

8.  Probability of cavitation for single ultrasound pulses applied to tissues and tissue-mimicking materials.

Authors:  Adam D Maxwell; Charles A Cain; Timothy L Hall; J Brian Fowlkes; Zhen Xu
Journal:  Ultrasound Med Biol       Date:  2013-02-04       Impact factor: 2.998

9.  Prostate histotripsy in an anticoagulated model.

Authors:  Jeffery C Wheat; Timothy L Hall; Christopher R Hempel; Charles A Cain; Zhen Xu; William W Roberts
Journal:  Urology       Date:  2009-11-22       Impact factor: 2.649

10.  First noninvasive thermal ablation of a brain tumor with MR-guided focused ultrasound.

Authors:  Daniel Coluccia; Javier Fandino; Lucia Schwyzer; Ruth O'Gorman; Luca Remonda; Javier Anon; Ernst Martin; Beat Werner
Journal:  J Ther Ultrasound       Date:  2014-10-16
View more
  14 in total

1.  Simulation of nonlinear trans-skull focusing and formation of shocks in brain using a fully populated ultrasound array with aberration correction.

Authors:  Pavel B Rosnitskiy; Petr V Yuldashev; Oleg A Sapozhnikov; Leonid R Gavrilov; Vera A Khokhlova
Journal:  J Acoust Soc Am       Date:  2019-09       Impact factor: 1.840

2.  Novel acoustic coupling bath using magnetite nanoparticles for MR-guided transcranial focused ultrasound surgery.

Authors:  Steven P Allen; Tom Steeves; Austin Fergusson; Dave Moore; Richey M Davis; Eli Vlaisialjevich; Craig H Meyer
Journal:  Med Phys       Date:  2019-10-29       Impact factor: 4.071

Review 3.  Focused ultrasound: growth potential and future directions in neurosurgery.

Authors:  Michael Zhang; Adrian Rodrigues; Quan Zhou; Gordon Li
Journal:  J Neurooncol       Date:  2021-08-19       Impact factor: 4.130

4.  Magnetic resonance imaging analysis predicts nanoparticle concentration delivered to the brain parenchyma.

Authors:  Michael Plaksin; Tiran Bercovici; Gabriella Gabi Sat Toltsis; Javier Grinfeld; Boaz Shapira; Yuval Zur; Rafi de Picciotto; Eyal Zadicario; Mustaffa Siddeeq; Anton Wohl; Zion Zibly; Yoav Levy; Zvi R Cohen
Journal:  Commun Biol       Date:  2022-09-15

5.  Two-step aberration correction: application to transcranial histotripsy.

Authors:  Ning Lu; Timothy L Hall; Jonathan R Sukovich; Sang Won Choi; John Snell; Nathan McDannold; Zhen Xu
Journal:  Phys Med Biol       Date:  2022-06-10       Impact factor: 4.174

Review 6.  The roles of thermal and mechanical stress in focused ultrasound-mediated immunomodulation and immunotherapy for central nervous system tumors.

Authors:  Chulyong Kim; Michael Lim; Graeme F Woodworth; Costas D Arvanitis
Journal:  J Neurooncol       Date:  2022-03-02       Impact factor: 4.506

7.  Transcranial Magnetic Resonance-Guided Histotripsy for Brain Surgery: Pre-clinical Investigation.

Authors:  Ning Lu; Dinank Gupta; Badih J Daou; Adam Fox; Dave Choi; Jonathan R Sukovich; Timothy L Hall; Sandra Camelo-Piragua; Neeraj Chaudhary; John Snell; Aditya S Pandey; Douglas C Noll; Zhen Xu
Journal:  Ultrasound Med Biol       Date:  2021-10-04       Impact factor: 3.694

8.  Image-Guided High-Intensity Focused Ultrasound, A Novel Application for Interventional Nuclear Medicine?

Authors:  Xinrui Zhang; Lisa Landgraf; Nikolaos Bailis; Michael Unger; Thies H Jochimsen; Andreas Melzer
Journal:  J Nucl Med       Date:  2021-06-04       Impact factor: 10.057

9.  Transcranial MR-Guided Histotripsy System.

Authors:  Ning Lu; Timothy L Hall; Dave Choi; Dinank Gupta; Badih Junior Daou; Jonathan R Sukovich; Adam Fox; Tyler I Gerhardson; Aditya S Pandey; Douglas C Noll; Zhen Xu
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2021-08-27       Impact factor: 3.267

10.  Real-Time Transcranial Histotripsy Treatment Localization and Mapping Using Acoustic Cavitation Emission Feedback.

Authors:  Jonathan R Sukovich; Jonathan J Macoskey; Jonathan E Lundt; Tyler I Gerhardson; Timothy L Hall; Zhen Xu
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2020-01-17       Impact factor: 2.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.